跳至主要内容
临床试验/NCT05301075
NCT05301075Unknown早期 1 期

Rhomboid Intercostal and Subserratus Plane (RISS) Block on Postoperative Painafter Open Nephrectomy Surgery

Cairo University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年3月21日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
入组人数
60
试验地点
1
主要终点
nalbuphine consumption i

研究概览

简要总结

Rhomboid intercostal block (RIB) is a new interfascial plane block describe by Elsharkawy et al. in 2016. The region described is understood because the triangle of auscultation that's bounded medially by inferior a part of the trapezius, inferiorly by the superior border of latissimus dorsi, and laterally by the medial border of the scapula. In this ultrasound-guided block, the local anaesthetic drug is run between the rhomboid major and therefore the intercostal fascia at the extent of T6-T7 and provides analgesia of T3-T8 dermatomes

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

control group

Sham Comparator

patients will receive sham block.

干预措施: Rhomboid Intercostal and Sub-Serratus block (Drug)

RISS group

Active Comparator

will receive Rhomboid Intercostal and Sub-Serratus block under ultrasound guidance

干预措施: Rhomboid Intercostal and Sub-Serratus block (Drug)

结局指标

主要结局

nalbuphine consumption i

时间窗: 24 hours

Postoperative nalbuphine consumption

次要结局

  • nalbuphine consumption.(2 hours)
  • Patient's satisfaction(24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amr Samir Wahdan

Lecturer of Anesthesia, Pain management and Surgical ICU

Cairo University

研究点 (1)

Loading locations...

相似试验